After weeks of threats, Trump announced on April 2 a series of broad tariffs on goods imported to the United States from most ...

Unfortunately, the same cannot be said for Europe. While it has been home to some of the most important biopharmaceutical companies in the world – many of which have consistently delivered ...

Preetika Rana is an award-winning reporter for The Wall Street Journal in San Francisco with experience reporting from six ...

Germany's Merck KGaA said on Thursday it is in late-stage talks to acquire U.S.-based SpringWorks Therapeutics for about $3.5 ...

America’s loss of dominance in mining to China was not inevitable—nor is its renewal. President Trump’s recent executive ...

Pharmaceutical company Novo Nordisk will expand its production site in Montes Claros, Brazil, creating 600 jobs.

Net sales of Cobenfy, whose success is imperative for Bristol Myers, totaled $27 million in the first quarter, handily ...

In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on site initiations, dosing ...

With potential tariffs and other drug pricing policies on the horizon, the industry is navigating uncertain waters. | The ...

Bristol-Myers Squibb Company's Q1 2025 earnings reveal revenue decline but EPS growth. Click to discover BMY challenges, ...

The U.S. equity market has stabilized in recent days as Trump has suggested he may back off certain tariffs. Stocks rose on Thursday, continuing the week's gains, though the broad-market S&P 500 is ...

The Swiss pharma giant made one of the most significant financial promises to bolster its domestic manufacturing capabilities as the Trump administration weighs levying tariffs on drugmakers.